We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+10.18%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.9B
AUM Growth
+$1.51B
(+4.1%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
12.97%
Holding
2,848
New
321
Increased
1,019
Reduced
1,065
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$488M |
| 2 |
Intel
INTC
|
+$363M |
| 3 |
Abbott
ABT
|
+$330M |
| 4 |
Baidu
BIDU
|
+$313M |
| 5 |
Amgen
AMGN
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$471M |
| 2 |
Microsoft
MSFT
|
+$457M |
| 3 |
Amazon
AMZN
|
+$428M |
| 4 |
Cisco
CSCO
|
+$385M |
| 5 |
Lowe's Companies
LOW
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Healthcare | 19.24% |
| 3 | Consumer Discretionary | 13.83% |
| 4 | Industrials | 10.04% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
2276
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $195K | ﹤0.01% |
46,300
-33,700
| -42% | -$143K |
|
2277
Inseego
INSG
$114M
| $190K | ﹤0.01% |
1,880
-1,310
| -41% | -$120K |
|
|
MPX
2278
DELISTED
Marine Products Corp
MPX
| $190K | ﹤0.01% |
12,300
+2,200
| +22% | +$36.5K |
|
|
TFFP
2279
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $189K | ﹤0.01% |
788
+252
| +47% | +$69.1K |
|
|
MTCR
2280
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $188K | ﹤0.01% |
49,400
+38,500
| +353% | +$159K |
|
2281
Yext
YEXT
$554M
| $187K | ﹤0.01% |
+13,100
| New | +$182K |
|
2282
Arcos Dorados Holdings
ARCO
$1.75B
| $186K | ﹤0.01% |
31,593
+12,374
| +64% | +$72.7K |
|
2283
American Vanguard Corp
AVD
$75.2M
| $179K | ﹤0.01% |
+10,200
| New | +$194K |
|
2284
Bioventus
BVS
$843M
| $176K | ﹤0.01% |
+10,000
| New | +$161K |
|
2285
Lifecore Biomedical
LFCR
$163M
| $174K | ﹤0.01% |
+15,464
| New | +$178K |
|
2286
Vinci Compass Investments Ltd
VINP
$637M
| $174K | ﹤0.01% |
+12,000
| New | +$157K |
|
|
HONE
2287
DELISTED
HarborOne Bancorp
HONE
| $173K | ﹤0.01% |
+12,030
| New | +$174K |
|
2288
KRONOS Worldwide
KRO
$705M
| $170K | ﹤0.01% |
+11,900
| New | +$193K |
|
2289
Immatics
IMTX
$1.18B
| $168K | ﹤0.01% |
14,500
+3,400
| +31% | +$39.9K |
|
|
NOA
2290
North American Construction
NOA
$376M
| $168K | ﹤0.01% |
+11,100
| New | +$148K |
|
2291
Velocity Financial
VEL
$692M
| $164K | ﹤0.01% |
+13,100
| New | +$139K |
|
|
CALA
2292
DELISTED
Calithera Biosciences, Inc
CALA
| $163K | ﹤0.01% |
3,910
-8,315
| -68% | -$365K |
|
|
VSA
2293
VisionSys AI
VSA
$9.08M
| $162K | ﹤0.01% |
23
+14
| +156% | +$119K |
|
2294
Genasys
GNSS
$74.2M
| $159K | ﹤0.01% |
29,100
+19,100
| +191% | +$117K |
|
|
BORR
2295
Borr Drilling
BORR
$1.27B
| $158K | ﹤0.01% |
97,051
-116,050
| -54% | -$219K |
|
2296
GEE Group
JOB
$23.2M
| $157K | ﹤0.01% |
274,300
+241,400
| +734% | +$161K |
|
2297
VYNE Therapeutics
VYNE
$19.1M
| $156K | ﹤0.01% |
49
-205
| -81% | -$811K |
|
|
RNTX
2298
Rein Therapeutics
RNTX
$66.9M
| $156K | ﹤0.01% |
6,240
-2,980
| -32% | -$74.3K |
|
|
DWTX
2299
Dogwood Therapeutics
DWTX
$51.5M
| $155K | ﹤0.01% |
988
-496
| -33% | -$70.3K |
|
|
RIBT
2300
DELISTED
RiceBran Technologies
RIBT
| $155K | ﹤0.01% |
+13,740
| New | +$138K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, Two Sigma Advisers held 2,848 positions worth $37.9B, up 4.1% from $36.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers withdrew a net $1.39B in Q2 2021, closing 428 positions and reducing 1,065 holdings. Its most notable exit was Cisco, an estimated $385M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Advisers opened a new position in Baidu worth $319M.
- Two Sigma Advisers's largest Q2 2021 buy was Baidu: 1,563,501 shares worth $319M.
- Two Sigma Advisers added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $488M increase.
- Two Sigma Advisers's biggest Q2 2021 reduction was Meta Platforms (Facebook), cutting an estimated $471M.
- Two Sigma Advisers fully exited Cisco in Q2 2021, selling an estimated $385M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $37.9B portfolio in Q2 2021.
- Two Sigma Advisers opened 321 new positions and closed 428 in Q2 2021.
- Two Sigma Advisers's portfolio value rose 4.1% quarter-over-quarter to $37.9B.
Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.